Piqur focuses on the discovery and development of innovative anti-cancer drugs based on the inhibition of the PI3K (phosphoinositide 3-kinase) and mTOR (mammalian target of rapamycin) pathways, one of the most promising research areas in oncology and clinically validated drug targets.

Company Name

Piqur Therapeutics

Company Website

https://www.piqur.com/

Location

Basel, Switzerland